Taylor Wessing advised Shield Therapeutics on securing $26 million debt and equity fundraising.Shield Therapeutics plc, a specialty pharmaceutical company listed on AIM, has secured a $20…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
